The Prospective Cohort Study to Evaluate the Preventive Efficacy of Quadrivalent HPV6/11/16/18 Vaccine in Japanese Women Aged 27-45 Years.
Conditions: Cancer of Cervix; Vaccinia Intervention: Biological: Gardasil Sponsors: University of Fukui; Merck Sharp & Dohme Corp. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer & Oncology | Cervical Cancer Vaccine | Gardasil | Japan Health | Research | Study | Vaccines | Women